← All votes
Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency
2024-04-10 · rejected · official record
Procedure: 2023/0131(COD) · amendment 378
Article 134, avant le § 1 - Am 378
At a glance
The recorded outcome was rejected. Against led by 354 votes. The available roll call contains 0 participating MEP records and is linked to procedure 2023/0131(COD).
Source and coverage
- Source last checked
- 28/08/2026, 06:01:26
- Record current through
- 2024-04-10
- Institution
- European Parliament
- Parliamentary term
- Not verified on this record
Coverage limitations: The individual-position record is incomplete or unavailable; published totals may be more complete than the table.
Read reporting and briefings ↗
For
96
Against
450
Abstention
36
Did not vote
0
Per-MEP breakdown not loaded for this vote.
Individual positions are loaded progressively from the source dataset. The summary above reflects the published totals.
Other votes in this procedure
2023/0131(COD) →- Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency2024-04-10 · main vote · adopted
- Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency2024-04-10 · amendment 373 · rejected
- Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency2024-04-10 · amendment 379 · rejected
- Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency2024-04-10 · amendment 377 · rejected
- Union procedures for the authorisation and supervision of medicinal products for human use and rules governing the European Medicines Agency2024-04-10 · amendment 368 · rejected
Data via HowTheyVote.eu (Open Database License), compiled from official European Parliament sources.